LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | SB590885 | 0.37 | uM | LJP5 | 72 | hr | 962 | 9190 | 10605 | 0.8666 | 0.8533 |
MCF 10A | PIK-93 | 0.37 | uM | LJP5 | 72 | hr | 962 | 9823 | 10605 | 0.9263 | 0.9190 |
MCF 10A | KIN001-043 | 0.37 | uM | LJP6 | 72 | hr | 962 | 9883 | 10605 | 0.9320 | 0.9252 |
MCF 10A | Alpelisib | 0.37 | uM | LJP5 | 72 | hr | 962 | 9803 | 10605 | 0.9244 | 0.9168 |
MCF 10A | Luminespib | 0.37 | uM | LJP5 | 72 | hr | 962 | 826 | 10605 | 0.0780 | -0.0141 |
MCF 10A | A443654 | 0.37 | uM | LJP6 | 72 | hr | 962 | 1706 | 10605 | 0.1609 | 0.0772 |
MCF 10A | OSI-027 | 0.37 | uM | LJP6 | 72 | hr | 962 | 2731 | 10605 | 0.2576 | 0.1835 |
MCF 10A | XMD11-85h | 0.37 | uM | LJP6 | 72 | hr | 962 | 10650 | 10605 | 1.0042 | 1.0047 |
MCF 10A | HG-6-64-01 | 0.37 | uM | LJP6 | 72 | hr | 962 | 10342 | 10605 | 0.9752 | 0.9728 |
MCF 10A | WH-4-025 | 0.37 | uM | LJP5 | 72 | hr | 962 | 7835 | 10605 | 0.7388 | 0.7127 |
MCF 10A | WZ-4-145 | 0.37 | uM | LJP6 | 72 | hr | 962 | 9478 | 10605 | 0.8938 | 0.8832 |
MCF 10A | XMD16-144 | 0.37 | uM | LJP5 | 72 | hr | 962 | 1603 | 10605 | 0.1512 | 0.0665 |
MCF 10A | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 962 | 10111 | 10605 | 0.9535 | 0.9488 |
MCF 10A | Buparlisib | 0.37 | uM | LJP5 | 72 | hr | 962 | 9430 | 10605 | 0.8893 | 0.8782 |
MCF 10A | BX-912 | 0.37 | uM | LJP5 | 72 | hr | 962 | 2387 | 10605 | 0.2251 | 0.1478 |
MCF 10A | Canertinib | 0.37 | uM | LJP6 | 72 | hr | 962 | 3517 | 10605 | 0.3316 | 0.2649 |
MCF 10A | Celastrol | 0.37 | uM | LJP6 | 72 | hr | 962 | 9824 | 10605 | 0.9264 | 0.9190 |
MCF 10A | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 962 | 263 | 10605 | 0.0249 | -0.0724 |
MCF 10A | CGP60474 | 0.37 | uM | LJP6 | 72 | hr | 962 | 277 | 10605 | 0.0262 | -0.0710 |
MCF 10A | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 962 | 11501 | 10605 | 1.0845 | 1.0930 |
MCF 10A | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 962 | 10536 | 10605 | 0.9935 | 0.9929 |
MCF 10A | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 962 | 10451 | 10605 | 0.9855 | 0.9841 |
MCF 10A | Crizotinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 9789 | 10605 | 0.9231 | 0.9154 |
MCF 10A | Momelotinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 8778 | 10605 | 0.8278 | 0.8106 |
MCF 10A | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 3086 | 10605 | 0.2911 | 0.2203 |